When COVID-19 was on the rise, ransomware attacks were right alongside it. A new investigation published in JAMA Health Forum found that ransomware attacks more than doubled in the last
Continue Reading Reduce Your Risk (And We’re Not Just Talking COVID-19 Vaccines)Two landmark cases fraught with False Claim Act (“FCA”) allegations of fraudulent billing for prescription drugs against food and pharmacy chains are making their way from the Seventh Circuit to
Continue Reading Is it Really Fraud? The Supreme Court Will Decide
As part of its ongoing effort to crack down on health care fraud related to COVID-19, the U.S. Justice Department has launched a coordinated law enforcement action that recently led
Continue Reading US Launches Coordinated Effort to Combat Health Care-Related COVID-19 Fraud
This post is a courtesy of Fox Rothschild attorneys Matthew D. Lee, Esq. and Marissa Koblitz Kingman, Esq., and was first published as an alert on Fox’s website.
The
Continue Reading Health Care Professionals Are Key Targets in COVID Aid-Related Fraud Prosecutions
This post is a courtesy of Fox Rothschild attorney William H. Maruca, Esq., and was first published as an Alert on Fox’s website.
A bipartisan bill introduced this summer
Continue Reading Proposed Amendments to False Claims Act Would Tilt the Playing Field
A nationwide telemedicine kickback scheme led to fraudulent Medicare reimbursements for durable medical equipment and genetic testing. The full Department of Justice press release can be found here.
Continue Reading Georgia Nurse Pleads Guilty to Telemedicine Fraud Scheme
A recent health care fraud conspiracy case resulted in federal prison sentences for six participants, serving as a warning to pharmacy owners and their employees. Read the full Department of
Continue Reading $8 Million Pharmacy Fraud Case Lands 6 Behind Bars
Fox Rothschild LLP partner, William Maruca, was recently interviewed for an article in Cosmos regarding the regulatory risks to hospitals and DME suppliers who enter into arrangements to ensure
Continue Reading Free Oxygen to COVID-19 Patients Upon Discharge Is Not Without Risk
Earlier this week, the Office of Inspector General OIG issued a Special Fraud Alert (Alert) on speaker programs by pharmaceutical and medical device companies in connection with the Federal Anti-Kickback
Continue Reading OIG Issues Special Fraud Alert on Speaker Programs
New guidance issued by the U.S. Department of Justice (DOJ) highlights the importance of updating corporate compliance programs to satisfy regulatory requirements. The 2020 updates pick up where the 2019
Continue Reading Have You Updated Your Corporate Compliance Program Lately?